screening to identify cancer and surveillance for recurrence
Evidence tells us that 1 in 2 of us will develop cancer during our lifetime. In the UK, there are 3 NHS screening programmes to help identify cancer early when we know that treatment is most effective and you can read more about these here Cancer Research UK – About NHS Cancer Screening
We offer a number of screening tests that can help to identify cancer at an earlier stage than conventional screening programmes – and can also help to identify a wider range of cancers. Our tests include TruCheck Breast, TruCheck Colon, TruCheck Prostate and TruCheck Diabetic (for those with type 2 diabetes who have a two-fold increase in their risk for pancreatic and liver cancer).
Our TruCheck Intelli Multicancer test is a wide screen panel and can identify up to 70 different cancers. Our TruCheck Fem panel screens for female cancers such as breast, cervical, uterine and ovarian cancer and is particularly important for those having HRT or deciding to start it.
After diagnosis and treatment for cancer, many patients will have ongoing surveillance to check for any recurrence. Usually this is based on physical examinations and imaging. Our CancerTrack test (a fasting blood test) can detect microscopic tumour DNA, often before it is clinically suspected, supporting the much earlier detection of recurrence if it does occur.
We also offer ROCA Care and ROCA Care at Home based on the ROCA Test for surveillance for ovarian cancer for those that are BRCA1 or BRCA2 carriers and have deferred risk reducing surgery and ovarian cancer screening based on a transvaginal ultrasound and CA125 blood test. Learn more about ovarian cancer and screening and ovarian cancer surveiilance.